МОЛЕКУЛЯРНО-ГЕНЕТИЧЕСКИЕ АСПЕКТЫ РАЗВИТИЯ ХРОНИЧЕСКОГО ПАНКРЕАТИТА РАЗЛИЧНОГО ГЕНЕЗА
Ключевые слова:
хронический панкреатит, молекулярно генетические аспекты.Аннотация
Хронический панкреатит (ХП) представляет собой прогрессирующее воспалительное заболевание поджелудочной железы, характеризующееся длительным течением и развитием фиброза, что может привести к нарушению функции органа. Несмотря на значительный прогресс в медицине, диагностика и лечение хронического панкреатита остаются сложными и многогранными задачами. Это связано с множеством факторов, таких как разнообразие этиологических факторов, поздняя диагностика заболевания и отсутствие универсальных методов терапии. Одним из важнейших аспектов в понимании патогенеза хронического панкреатита является молекулярно-генетический подход. Генетическая предрасположенность играет ключевую роль в развитии заболевания, и в последние десятилетия было выявлено несколько генов, которые могут способствовать развитию ХП различного генеза.
Библиографические ссылки
Etemad B, Whitcomb DC: Chronic pancreatitis: diagnosis, classification, and new genetic developments. Gastroenterology, 2001; 120: 682–707
Witt H: Chronic pancreatitis and cystic fibrosis. Gut, 2003; 52(Suppl.2): ii31–41
Comfort M, Steinberg A: Pedigree of a family with hereditary chronic relapsing pancreatitis. Gastroenterology, 1952; 21: 54–63
Keim V, Bauer N, Teich N et al: Clinical characteristics of patients with hereditary pancreatitis and mutations in cationic trypsinogen. Am J Med, 2001; 111: 622–26
Moir CR, Konzen KM, Perrault J: Surgical therapy and long-term follow-up of childhood hereditary pancreatitis. J Pediatr Surg, 1992; 27: 282–86
Miller AR, Nagorney DM, Sarr MG: The surgical spectrum of hereditary pancreatitis in adults. Ann Surg, 1992; 215: 39–43
Lowenfels AB, Maisonneuve P, DiMagno EP et al: Hereditary pancreatitis and the risk of pancreatic cancer. International Hereditary Pancreatitis Study Group. J Natl Cancer Inst, 1997; 89: 442–46
Ulrich CD: Pancreatic Cancer in Hereditary Pancreatitis: Consensus Guidelines for Prevention, Screening and Treatment. Pancreatology, 2001; 1: 416–22
Whitcomb DC, Gorry MC, Preston RA et al: Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene. Nat Genet, 1996; 14: 141–45
Gorry MC, Gabbaizedeh D, Furey W et al: Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis. Gastroenterology, 1997; 113: 1063–68
Witt H, Luck W, Becker M: A signal peptide cleavage site mutation in the cationic trypsinogen gene is strongly associated with chronic pancreatitis. Gastroenterology, 1999; 117: 7–10
Teich N, Bauer N, Mössner J, Keim V: Mutational screening of patients with nonalcoholic chronic pancreatitis: Identification of further trypsinogen variants. Am J Gastroenterol, 2002; 97: 341–46
Kukor Z, Mayerle J, Kruger B et al: Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis. Biol Chem, 2000; 277: 21389–96
Kukor Z, Toth M, Pal G, Sahin-Toth M: Human cationic trypsinogen. Arg(117) is the reactive site of an inhibitory surface loop that controls spontaneous zymogen activation. J Biol Chem, 2002; 277: 6111–17
Sahin-Toth M: Human cationic trypsinogen. Role of Asn-21 in zymogen activation and implications in hereditary pancreatitis. J Biol Chem, 2000; 275: 22750–55
Sahin-Toth M. The pathobiochemistry of hereditary pancreatitis: studies on recombinant human cationic trypsinogen. Pancreatology, 2001; 1: 461–65
Sahin-Toth M, Toth M: Gain-of-function mutations associated with hereditary pancreatitis enhance autoactivation of human cationic trypsinogen. Biochem Biophys Res Commun, 2000; 278: 286–89
Simon P, Weiss FU, Sahin-Toth M et al: Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122->Cys) that alters autoactivation and autodegradation of cationic trypsinogen. J Biol Chem, 2002; 277: 5404–10
Szilagyi L, Kenesi E, Katona G et al: Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis. J Biol Chem, 2001; 276: 24574–80
Teich N, Ockenga J, Hoffmeister A et al: Chronic pancreatitis associated with an activation peptide mutation that facilitates trypsin activation. Gastroenterology, 2000; 119: 461–65
JA Rizaev , I. R. Agababyan , YAIsmoilova ACTIVITIES OF CLINICS SPECIALIZING IN THE TREATMENT OF PATIENTS WITH CHRONIC HEART DISEASE IN THE WORLD (REFERENCES). Journal of Biomedicine and Practice. 2021, vol. 6, issue 6, pp. 184-191
Makhmonov L.S., Rizaev Zh.A., Gadaev A.G. HELICOBACTER PYLORI AND ITS IMPORTANCE IN THE DEVELOPMENT OF ANEMIA ASSOCIATED WITH IRON DEFICIENCY AND VITAMIN B12 // Problems of biology and medicine. - 2021. No. 5. Volume . 130. - S. 215-218.
Irgashev, K. N., & Rizaev, J. A. (2025). Optimization of clinical outcomes in the rehabilitation of patients with non-caries dental lesions manifesting as pathological abrasion. Medical Research Journal, 1(1), 146–151.
Shavkatovna, S. S., Makhammatkulovich, R. N., & Ugli, M. S. T. (2024). Aspects of sarcopenia syndrome in oncological practice: Diagnosis and treatment. The American Journal of Medical Sciences and Pharmaceutical Research, 6(2).
Shakhanova, S. S., & Rakhimov, N. M. (2025). The role of troponin and IL-6 in immunological assessment of sarcopenia in oncological patients. Central Asian Journal of Medical and Natural Science, 6(3), 1229–1233.
Rakhimov, N. M., & Shakhanova, S. Sh. (2025). Omega-3 supplementation in combination therapy for anorexia syndrome in metastatic breast cancer. American Journal of Medicine and Medical Sciences.
